GlassScriptPhysician profile
Latresha J Mcbride
NPI 1255522447
$2,949.87
in general payments reported to CMS, 2019-2025
21 companies · $134 in 2025
The $134 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $180 · 2021: $528 · 2022: $859 · 2023: $451 · 2024: $392 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $834.53 | 2021-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $588.17 | 2021-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Ironshore Pharmaceuticals INC. | $540.08 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $223.76 | 2019 | |
| Sanofi Pasteur INC. | $166.53 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $100.35 | 2020 | |
| Corium, LLC | $79.31 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $73.55 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $66.11 | 2023-2024 | Pediarix, Bexsero, Rotarix |
| Cranial Technologies, INC | $54.09 | 2019-2023 | Doc Band |
| Organon LLC | $42.45 | 2021-2023 | Nexplanon |
| Otsuka America Pharmaceutical, INC. | $33.84 | 2023-2024 | Abilify Maintena |
| Lilly USA, LLC | $24.50 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $24.25 | 2020-2021 | |
| Adlon Therapeutics L.P. | $17.00 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.58 | 2022 | |
| Neos Therapeutics, LP | $15.71 | 2019 | |
| Livanova USA, INC. | $15.47 | 2019 | |
| Tactile Systems Technology INC | $12.70 | 2022 | |
| Dexcom, INC. | $12.04 | 2020 | |
| Meridian Bioscience INC. | $8.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latresha Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.